OneLab
Latent Space Therapeutics is an innovative AI-driven virtual drug company focused on developing groundbreaking medicines for challenging cancers and complex diseases. By leveraging advanced AI technology, the company conducts comprehensive in-silico testing for retrosynthesis, toxicity, and efficacy, significantly accelerating the drug discovery process. Their unique platform identifies promising therapeutic candidates at an unprecedented pace, reducing both time and costs associated with traditional drug development. With a dedicated team of engineers and scientists, Latent Space Therapeutics is pioneering the development of novel medicines, prioritizing drug design based on efficacy and safety before identifying specific targets.
OneLab
Latent Space Therapeutics is an innovative AI-driven virtual drug company focused on developing groundbreaking medicines for challenging cancers and complex diseases. By leveraging advanced AI technology, the company conducts comprehensive in-silico testing for retrosynthesis, toxicity, and efficacy, significantly accelerating the drug discovery process. Their unique platform identifies promising therapeutic candidates at an unprecedented pace, reducing both time and costs associated with traditional drug development. With a dedicated team of engineers and scientists, Latent Space Therapeutics is pioneering the development of novel medicines, prioritizing drug design based on efficacy and safety before identifying specific targets.